HK Stock Movement | Xuanzhu Biopharm-B (02575.HK) Surges Over 40% in Afternoon Session, Signs Tripartite Commercial Agreement with Thailand's Innobic for Palbociclib Tablets

Zhito Finance APP has learned that Xuanzhu Biopharm-B (02575.HK) surged over 40% in the afternoon. As of press time, it was up 34.69%, at HK$10.95, with a turnover of HK$92.8993 million.